Omega 3 Index Study

Omega 3 Index Study - Omega 3 Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028617

Enrollment

Registered

2023-03-13

Start date

2021-07-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Omega 3 index, atherosclerosis, cardiovascular risk factors dyslipoproteinemia

Interventions

Group 1: Intervention with fishoil Phase 1: 13 weeks 1500 mg omega 3 fatty acids from fish oil, with 780 mg eicosapentaenoic acid und 495 mg docosahexaenoic acid Phase 2: 13 weeks 750 mg omega 3 fatt

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: voluntary, adult

Exclusion criteria

Exclusion criteria: allgery against fish, hematophobia, coagulation disorder

Design outcomes

Primary

Measure	Time frame
HS omega 3 index = share of EPA and DHA on total fatty acids in the membranes of red blood cells in capillary blood samples before and after 13 weeks of intervention with a daily intake of 1500 mg omega 3 fatty acids and additional 13 weeks with 750 mg omega 3 fatty acids.	—

Secondary

Measure	Time frame
triglyceride, total cholesterol, HDL and LDL concentrations measured in capillary blood cells and blood pressure.	—

Countries

Germany

Contacts

Public ContactSandra Habicht

Justus Liebig Universität, Institut für Ernährungswissenschaft

Sandra.D.Habicht@ernaehrung.uni-giessen.de0641 99 39 346

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026